{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:40:51Z","timestamp":1790977251487,"version":"4.1.0"},"reference-count":70,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:00:00Z","timestamp":1626048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Study Objectives<\/jats:title>\n                  <jats:p>It is known that antidepressant drugs can induce sleep disorders in patients, but little data exist about high or low-risk molecules. The aim was to study the frequency of antidepressant drug-induced sleep disorders (DISD) by molecule.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>77,391 patient comments for 32 antidepressant drugs were collected from drug review websites and screened for DISD. Association between drugs and nightmare disorder, restless legs syndrome, sleep paralysis, sleep terrors, sleep-related hallucinations, or sleep walking was expressed as relative proportion [proportional reporting ratio (PRR)]. A detailed analysis of the content of the dreams was also carried out.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Amitriptyline, doxepin, fluvoxamine, mirtazapine, nortriptyline, trazodone, venlafaxine, and vilazodone were associated with a greater frequency of DISD compared to other antidepressants. Vilazodone heavily increased the probability of developing 5 of the 6 studied DISD (PRR 3.3 to 19.3) and mirtazapine increased the probability of developing 4 DISD (PRR 2.4 to 6.4). Bupropion and citalopram were associated with lower probabilities for 5 DISD (PRR 0.2 to 0.7). Sentiment analysis showed that patients described disturbing dreams for vilazodone or mirtazapine and strange but less negative dreams for bupropion, citalopram, or duloxetine.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Relative frequencies of sleep disorders were obtained for a vast panel of antidepressant drugs through an original analysis of user\u2019s drug reviews on drug rating websites. Our results could guide clinicians in the appropriate choice of antidepressant drugs for high DISD-risk patients in need of such treatment. These results may however be cautiously taken, considering the uncertain reliability and generalizability of web-based data.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/sleep\/zsab174","type":"journal-article","created":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T18:20:50Z","timestamp":1626114050000},"source":"Crossref","is-referenced-by-count":9,"title":["Relative frequency of drug-induced sleep disorders for 32 antidepressants in a large set of Internet user reviews"],"prefix":"10.1093","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1479-3692","authenticated-orcid":false,"given":"Johan","family":"Natter","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy, University of Strasbourg , Strasbourg , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7554-4307","authenticated-orcid":false,"given":"Ta\u00efoh","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Strasbourg , Strasbourg , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5961-1584","authenticated-orcid":false,"given":"Bruno","family":"Michel","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Strasbourg , Strasbourg , France"},{"name":"Department of Pharmacy, University Hospital of Strasbourg , Strasbourg , France"},{"name":"Laboratory of Neuro-cardio vascular Pharmacology and Toxicology UR7296, University of Strasbourg , Strasbourg , France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,12]]},"reference":[{"issue":"35\u201336","key":"2022092917583881600_CIT0001","first-page":"1135","article-title":"Treatment of depressive states with an iminodibenzyl derivative (G 22355)","volume":"87","author":"Kuhn","year":"1957","journal-title":"Schweiz Med Wochenschr."},{"issue":"10","key":"2022092917583881600_CIT0002","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/jama.1952.03680100015006","article-title":"Treatment of pulmonary tuberculosis with hydrazide derivatives of isonicotinic acid","volume":"150","author":"Selikoff","year":"1952","journal-title":"J Am Med Assoc."},{"key":"2022092917583881600_CIT0003","author":"McQuaid","year":"2019"},{"issue":"Suppl 11","key":"2022092917583881600_CIT0004","first-page":"9","article-title":"New indications for antidepressants","volume":"61","author":"Schatzberg","year":"2000","journal-title":"J Clin Psychiatry."},{"issue":"5","key":"2022092917583881600_CIT0005","first-page":"CD010753","article-title":"Antidepressants for insomnia in adults","author":"Everitt","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2022092917583881600_CIT0006","doi-asserted-by":"crossref","first-page":"482","DOI":"10.21037\/tau.2016.06.10","article-title":"The drug treatment of premature ejaculation","volume":"5","author":"Hisasue","year":"2016","journal-title":"Transl Androl Urol."},{"issue":"3","key":"2022092917583881600_CIT0007","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5056\/jnm.2011.17.3.305","article-title":"Psychiatric co-morbidity and efficacy of mirtazapine treatment in young subjects with chronic or cyclic vomiting syndromes: a case series","volume":"17","author":"Coskun","year":"2011","journal-title":"J Neurogastroenterol Motil."},{"issue":"5","key":"2022092917583881600_CIT0008","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s40263-016-0337-4","article-title":"Treatment options for narcolepsy","volume":"30","author":"Barateau","year":"2016","journal-title":"CNS Drugs."},{"issue":"2","key":"2022092917583881600_CIT0009","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jsmc.2018.02.003","article-title":"Drugs used in parasomnia","volume":"13","author":"Proserpio","year":"2018","journal-title":"Sleep Med Clin."},{"key":"2022092917583881600_CIT0010","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.sleep.2018.03.021","article-title":"NREM parasomnias: a treatment approach based upon a retrospective case series of 512 patients","volume":"53","author":"Drakatos","year":"2019","journal-title":"Sleep Med."},{"issue":"9","key":"2022092917583881600_CIT0011","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.4088\/JCP.v69n0904","article-title":"Parasomnia among psychiatric outpatients: a clinical, epidemiologic, cross-sectional study","volume":"69","author":"Lam","year":"2008","journal-title":"J Clin Psychiatry."},{"issue":"11","key":"2022092917583881600_CIT0012","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.5665\/sleep.3102","article-title":"Antidepressants and REM sleep behavior disorder: isolated side effect or neurodegenerative signal?","volume":"36","author":"Postuma","year":"2013","journal-title":"Sleep."},{"key":"2022092917583881600_CIT0013","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fpsyt.2011.00071","article-title":"Parasomnias and antidepressant therapy: a review of the literature","volume":"2","author":"Kierlin","year":"2011","journal-title":"Front Psychiatry."},{"issue":"6","key":"2022092917583881600_CIT0014","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2850.2008.01250.x","article-title":"Perceived sleep quality of psychiatric patients","volume":"15","author":"Niet De","year":"2008","journal-title":"J Psychiatr Ment Health Nurs"},{"issue":"1\u20133","key":"2022092917583881600_CIT0015","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.schres.2012.05.013","article-title":"Effects of polypharmacy on sleep in psychiatric inpatients","volume":"139","author":"Waters","year":"2012","journal-title":"Schizophr Res."},{"key":"2022092917583881600_CIT0016","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.smrv.2017.01.005","article-title":"Medication induced sleepwalking: a systematic review","volume":"37","author":"Stallman","year":"2018","journal-title":"Sleep Med Rev."},{"key":"2022092917583881600_CIT0017","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.smrv.2017.06.002","article-title":"The influence of antidepressants on restless legs syndrome and periodic limb movements: a systematic review","volume":"38","author":"Kolla","year":"2018","journal-title":"Sleep Med Rev."},{"issue":"6","key":"2022092917583881600_CIT0018","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/JCP.0b013e318272cdd8","article-title":"Drugs associated with restless legs syndrome: a case\/noncase study in the French Pharmacovigilance Database","volume":"32","author":"Perez-Lloret","year":"2012","journal-title":"J Clin Psychopharmacol."},{"issue":"7","key":"2022092917583881600_CIT0019","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11920-017-0789-3","article-title":"Psychiatric illness and parasomnias: a systematic review","volume":"19","author":"Waters","year":"2017","journal-title":"Curr Psychiatry Rep."},{"key":"2022092917583881600_CIT0020","author":"Fox","year":"2013"},{"key":"2022092917583881600_CIT0021","author":"Hardwick","year":"2020"},{"key":"2022092917583881600_CIT0022","first-page":"121","article-title":"Aspect-based sentiment analysis of drug reviews applying cross-domain and cross-data learning.","author":"Gr\u00e4\u00dfer","year":"2018"},{"issue":"6S","key":"2022092917583881600_CIT0023","doi-asserted-by":"crossref","first-page":"S364","DOI":"10.1016\/j.arth.2019.11.021","article-title":"Patient-recorded physician ratings: what can we learn from 11,527 online reviews of orthopedic surgeons?","volume":"35","author":"Yu","year":"2020","journal-title":"J Arthroplasty."},{"key":"2022092917583881600_CIT0024","first-page":"201","article-title":"Analysis of inter-domain and cross-domain drug review polarity classification","volume":"2020","author":"Gurdin","year":"2020","journal-title":"AMIA Jt Summits Transl Sci Proc."},{"key":"2022092917583881600_CIT0025","volume-title":"R: A Language and Environment for Statistical Computing.","author":"R Core Team","year":"2020"},{"key":"2022092917583881600_CIT0026","author":"Wickham","year":"2020"},{"key":"2022092917583881600_CIT0027","author":"Wickham","year":"2020"},{"key":"2022092917583881600_CIT0028","doi-asserted-by":"crossref","first-page":"103838","DOI":"10.1016\/j.dib.2019.103838","article-title":"The PsyTAR dataset: from patients generated narratives to a corpus of adverse drug events and effectiveness of psychiatric medications","volume":"24","author":"Zolnoori","year":"2019","journal-title":"Data Brief."},{"key":"2022092917583881600_CIT0029","doi-asserted-by":"crossref","first-page":"103091","DOI":"10.1016\/j.jbi.2018.12.005","article-title":"A systematic approach for developing a corpus of patient reported adverse drug events: a case study for SSRI and SNRI medications","volume":"90","author":"Zolnoori","year":"2019","journal-title":"J Biomed Inform."},{"key":"2022092917583881600_CIT0030","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013","edition":"5th ed"},{"issue":"11","key":"2022092917583881600_CIT0031","first-page":"CD010628","article-title":"Pharmacological interventions for somatoform disorders in adults","author":"Kleinst\u00e4uber","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2022092917583881600_CIT0032","volume-title":"stringr: Simple, Consistent Wrappers for Common String Operations","author":"Wickham","year":"2019"},{"issue":"6","key":"2022092917583881600_CIT0033","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pds.677","article-title":"Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports","volume":"10","author":"Evans","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"3","key":"2022092917583881600_CIT0034","doi-asserted-by":"crossref","DOI":"10.21105\/joss.00037","article-title":"tidytext: text mining and analysis using tidy data principles in R","volume":"1","author":"Silge","year":"2016","journal-title":"JOSS"},{"issue":"2-3","key":"2022092917583881600_CIT0035","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0165-1781(00)00227-4","article-title":"Prevalence of hallucinations and their pathological associations in the general population","volume":"97","author":"Ohayon","year":"2000","journal-title":"Psychiatry Res."},{"issue":"4","key":"2022092917583881600_CIT0036","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.smrv.2011.05.002","article-title":"Epidemiology of restless legs syndrome: a synthesis of the literature","volume":"16","author":"Ohayon","year":"2012","journal-title":"Sleep Med Rev."},{"issue":"12","key":"2022092917583881600_CIT0037","first-page":"e3807","article-title":"Parasomnias: a comprehensive review","volume":"10","author":"Singh","year":"2018","journal-title":"Cureus"},{"key":"2022092917583881600_CIT0038","author":"Chung","year":"2018"},{"issue":"4","key":"2022092917583881600_CIT0039","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.ncl.2010.03.025","article-title":"Treatment options for parasomnias","volume":"28","author":"Attarian","year":"2010","journal-title":"Neurol Clin."},{"issue":"3","key":"2022092917583881600_CIT0040","first-page":"215","article-title":"The effects of mirtazapine on sleep in patients with major depressive disorder","volume":"24","author":"Dolder","year":"2012","journal-title":"Ann Clin Psychiatry."},{"issue":"5","key":"2022092917583881600_CIT0041","doi-asserted-by":"crossref","first-page":"661","DOI":"10.5665\/sleep.2622","article-title":"Mirtazapine provokes periodic leg movements during sleep in young healthy men","volume":"36","author":"Fulda","year":"2013","journal-title":"Sleep."},{"issue":"4","key":"2022092917583881600_CIT0042","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4103\/tcmj.tcmj_13_20","article-title":"Mirtazapine-associated movement disorders: a literature review","volume":"32","author":"Rissardo","year":"2020","journal-title":"Tzu Chi Med J."},{"issue":"7","key":"2022092917583881600_CIT0043","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/hup.965","article-title":"Factors potentiating the risk of mirtazapine-associated restless legs syndrome","volume":"23","author":"Kim","year":"2008","journal-title":"Hum Psychopharmacol."},{"issue":"12","key":"2022092917583881600_CIT0044","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.4088\/JCP.v63n1214a","article-title":"Restless legs syndrome induced by mirtazapine","volume":"63","author":"A\u011farg\u00fcn","year":"2002","journal-title":"J Clin Psychiatry."},{"issue":"2","key":"2022092917583881600_CIT0045","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1440-1819.2002.00955.x","article-title":"Mirtazapine may have the propensity for developing a restless legs syndrome? A case report","volume":"56","author":"Bahk","year":"2002","journal-title":"Psychiatry Clin Neurosci."},{"issue":"5","key":"2022092917583881600_CIT0046","first-page":"655","article-title":"Mirtazapine and restless leg syndrome: a case report","volume":"55","author":"Bonin","year":"2000","journal-title":"Therapie."},{"issue":"4","key":"2022092917583881600_CIT0047","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-0043-105076","article-title":"Mirtazapine induces nightmares in depressed patients","volume":"50","author":"Buschkamp","year":"2017","journal-title":"Pharmacopsychiatry."},{"issue":"2","key":"2022092917583881600_CIT0048","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.pnpbp.2005.10.001","article-title":"Does domperidone potentiate mirtazapine-associated restless legs syndrome?","volume":"30","author":"Chang","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"2022092917583881600_CIT0049","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.psym.2010.11.009","article-title":"Mirtazapine-induced worsening of restless legs syndrome (RLS) and ropinirole-induced psychosis: challenges in management of depression in RLS","volume":"52","author":"Chopra","year":"2011","journal-title":"Psychosomatics."},{"issue":"1","key":"2022092917583881600_CIT0050","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2125.2008.03305.x","article-title":"Mirtazapine induced nightmares in an adult male","volume":"67","author":"Dang","year":"2009","journal-title":"Br J Clin Pharmacol."},{"issue":"4","key":"2022092917583881600_CIT0051","doi-asserted-by":"crossref","first-page":"145e","DOI":"10.1592\/phco.30.4.423","article-title":"Acute psychosis associated with dissociated sleep-wakefulness state after mirtazapine treatment","volume":"30","author":"Felthous","year":"2010","journal-title":"Pharmacotherapy."},{"issue":"1","key":"2022092917583881600_CIT0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15761\/GMC.1000102","article-title":"Mirtazapine for suspected REM sleep behavior disorder and depression: a case report","volume":"1","author":"Jennifer","year":"2017","journal-title":"Geriatr Med Care."},{"issue":"5","key":"2022092917583881600_CIT0053","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4088\/PCC.v08n0510b","article-title":"Mirtazapine-induced nightmares","volume":"8","author":"Mathews","year":"2006","journal-title":"Prim Care Companion J Clin Psychiatry."},{"issue":"4","key":"2022092917583881600_CIT0054","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4103\/jpp.JPP_116_17","article-title":"Low-dose mirtazapine-induced nightmares necessitating its discontinuation in a young adult female","volume":"8","author":"Menon","year":"2017","journal-title":"J Pharmacol Pharmacother."},{"issue":"1","key":"2022092917583881600_CIT0055","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1212\/01.WNL.0000042084.03066.C0","article-title":"Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism","volume":"60","author":"Onofrj","year":"2003","journal-title":"Neurology."},{"issue":"6","key":"2022092917583881600_CIT0056","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1440-1819.2004.01319.x","article-title":"Re-administration of mirtazapine could overcome previous mirtazapine-associated restless legs syndrome?","volume":"58","author":"Pae","year":"2004","journal-title":"Psychiatry Clin Neurosci."},{"issue":"11","key":"2022092917583881600_CIT0057","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.4088\/JCP.v67n1122d","article-title":"Fluoxetine-mirtazapine interaction may induce restless legs syndrome: report of 3 cases from a clinical trial","volume":"67","author":"Prospero-Garcia","year":"2006","journal-title":"J Clin Psychiatry."},{"key":"2022092917583881600_CIT0058","article-title":"Nightmares and mirtazapine\u2014time to be vigilant","author":"Sudha","year":"2020","journal-title":"Indian J Psychol Med."},{"issue":"4","key":"2022092917583881600_CIT0059","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/WNF.0b013e318187bafc","article-title":"New onset somnambulism associated with different dosage of mirtazapine: a case report","volume":"32","author":"Yeh","year":"2009","journal-title":"Clin Neuropharmacol."},{"issue":"6","key":"2022092917583881600_CIT0060","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/JCP.0000000000000574","article-title":"Nightmares associated with vilazodone in a patient with major depressive disorder","volume":"36","author":"De Sousa","year":"2016","journal-title":"J Clin Psychopharmacol."},{"issue":"3","key":"2022092917583881600_CIT0061","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/2045125311409486","article-title":"Vilazodone: a brief pharmacological and clinical review of the novel serotonin partial agonist and reuptake inhibitor","volume":"1","author":"Schwartz","year":"2011","journal-title":"Ther Adv Psychopharmacol."},{"issue":"Suppl 4","key":"2022092917583881600_CIT0062","first-page":"19","article-title":"The pharmacologic profile of mirtazapine","volume":"57","author":"de Boer","year":"1996","journal-title":"J Clin Psychiatry."},{"issue":"3","key":"2022092917583881600_CIT0063","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1017\/S1461145704004298","article-title":"Effect of treatment with bupropion on EEG sleep: relationship to antidepressant response","volume":"7","author":"Ott","year":"2004","journal-title":"Int J Neuropsychopharmacol."},{"issue":"2","key":"2022092917583881600_CIT0064","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.euroneuro.2013.09.007","article-title":"Bupropion response on sleep quality in patients with depression: implications for increased cardiovascular disease risk","volume":"24","author":"Schramm","year":"2014","journal-title":"Eur Neuropsychopharmacol."},{"issue":"4","key":"2022092917583881600_CIT0065","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3122\/jabfm.2011.04.100173","article-title":"Bupropion and restless legs syndrome: a randomized controlled trial","volume":"24","author":"Bayard","year":"2011","journal-title":"J Am Board Fam Med."},{"issue":"8","key":"2022092917583881600_CIT0066","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1177\/0269881109349835","article-title":"Escitalopram\u2013translating molecular properties into clinical benefit: reviewing the evidence in major depression","volume":"24","author":"Leonard","year":"2010","journal-title":"J Psychopharmacol."},{"issue":"1","key":"2022092917583881600_CIT0067","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000074435","article-title":"Escitalopram: superior to citalopram or a chiral chimera?","volume":"73","author":"Svensson","year":"2004","journal-title":"Psychother Psychosom."},{"issue":"7","key":"2022092917583881600_CIT0068","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2165\/00003495-200565070-00003","article-title":"Antidepressants and sleep: a qualitative review of the literature","volume":"65","author":"Wilson","year":"2005","journal-title":"Drugs."},{"issue":"1","key":"2022092917583881600_CIT0069","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1087-0792(97)90006-X","article-title":"REM sleep behavior disorder: clinical and physiopathological findings","volume":"1","author":"Sforza","year":"1997","journal-title":"Sleep Med Rev."},{"key":"2022092917583881600_CIT0070","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jbi.2014.11.002","article-title":"Portable automatic text classification for adverse drug reaction detection via multi-corpus training","volume":"53","author":"Sarker","year":"2015","journal-title":"J Biomed Inform."}],"container-title":["Sleep"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/sleep\/advance-article-pdf\/doi\/10.1093\/sleep\/zsab174\/39455924\/zsab174.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/sleep\/article-pdf\/44\/12\/zsab174\/46202722\/zsab174.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/sleep\/article-pdf\/44\/12\/zsab174\/46202722\/zsab174.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T18:01:13Z","timestamp":1664474473000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/sleep\/article\/doi\/10.1093\/sleep\/zsab174\/6319622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,12]]},"references-count":70,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,7,12]]},"published-print":{"date-parts":[[2021,12,10]]}},"URL":"https:\/\/doi.org\/10.1093\/sleep\/zsab174","relation":{},"ISSN":["0161-8105","1550-9109"],"issn-type":[{"value":"0161-8105","type":"print"},{"value":"1550-9109","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,1]]},"published":{"date-parts":[[2021,7,12]]},"article-number":"zsab174"}}